Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glycomimetics Inc
(NQ:
GLYC
)
1.925
-0.235 (-10.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Glycomimetics Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023
March 27, 2024
GLYC stock results show that GlycoMimetics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Outlook For GlycoMimetics
March 26, 2024
Via
Benzinga
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
March 21, 2024
Glycomimetics' Uproleselan is expected to read out data in relapsed/refractory and elderly newly diagnosed Acute Myeloid Leukemia (AML) after 6 years in pivotal studies.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 24, 2024
Via
Benzinga
Earnings Outlook For GlycoMimetics
November 02, 2023
Via
Benzinga
GlycoMimetics: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Earnings Preview For GlycoMimetics
March 28, 2023
Via
Benzinga
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
January 03, 2024
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan....
Via
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
May 09, 2023
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 21, 2023
Via
Benzinga
$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying
February 21, 2023
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday
February 16, 2023
Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05...
Via
Benzinga
Nasdaq Surges 90 Points; Credo Technology Group Shares Slide
February 15, 2023
U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to...
Via
Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 15, 2023
Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
Via
Benzinga
Gold Down 1%; Roblox Shares Spike Higher
February 15, 2023
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 15, 2023
Via
Benzinga
Dow Dips 200 Points; US Retail Sales Rise 3%
February 15, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.61% to 33,880.45 while the NASDAQ fell...
Via
Benzinga
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
February 13, 2023
Dan Cohen and Scott Matusow discuss In this 1:11 audio the upcoming data sets for Glycomimetics. We talk about The Company's platform chemistry in depth, and give our predictions for success/failure of...
Via
Talk Markets
Top 5 Health Care Stocks That May Dip
January 27, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
December 28, 2022
The Dow Jones settled slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
US Stocks Rise; Dow Gains 100 Points
December 28, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...
Via
Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
December 15, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.